In this issue of Cardiology Clinics, guest editors Drs. Eric H. Yang and Ashley F. Stein-Merlob bring their considerable expertise to the topic of Cardio-oncology. Top experts discuss key topics such as anthracycline-induced cardiotoxicity; cardiac complications of immunotherapy: immune checkpoint inhibitors and CAR T cell therapy; advances in diagnosis and treatment of amyloid cardiomyopathy; guidelines in cardio-oncology; and more.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Preface - p. xiii 8. Cardiovascular Risk Assessment and Prevention in Cardio-Oncology: Beyond Traditional Risk Factors - p. 1 9. Clonal Hematopoiesis of Indeterminate Potential and Cardiovascular Health - p. 13 10. Unique Challenges of Adult Congenital Heart Disease in CardioOncology - p. 25 11. Classes of Antineoplastic Agents Associated with Increased Risk of Cancer Therapy-associated Hypertension and Management Strategies - p. 31 12. Arrhythmia Challenges in Cardio-Oncology: High-Risk Therapies, Management, and Anticoagulation - p. 43 13. Ischemic Heart Disease in the Cancer Population: Trends, Outcomes, Epidemiology, and Challenges in Diagnosis and Treatment - p. 57 14. Cardiovascular Health in Breast Cancer: Survivorship Care - p. 69 15. Cardiovascular Risk in Prostate Cancer - p. 83 16. Evolving Strategies in Cardiac Amyloidosis: From Mechanistic Discoveries to Diagnostic and Therapeutic Advances - p. 93 17. Cardiotoxicity of Anthracyclines - p. 111 18. Cardiac Complications of Radiation Therapy - p. 129 19. Cardiac Complications of Immune Checkpoint Inhibitors and Chimeric Antigen Receptor T Cell Therapy - p. 151 20. Cardio-oncology Drug Interactions: A Primer for Clinicians on Select Cardiotoxic Oncologic Therapies - p. 169 21. Cardio-Oncology Program Building: A Practical Guide - p. 195
In this issue of Cardiology Clinics, guest editors Drs. Eric H. Yang and Ashley F. Stein-Merlob bring their considerable expertise to the topic of Cardio-oncology. Top experts discuss key topics such as anthracycline-induced cardiotoxicity; cardiac complications of immunotherapy: immune checkpoint inhibitors and CAR T cell therapy; advances in diagnosis and treatment of amyloid cardiomyopathy; guidelines in cardio-oncology; and more.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Preface - p. xiii 8. Cardiovascular Risk Assessment and Prevention in Cardio-Oncology: Beyond Traditional Risk Factors - p. 1 9. Clonal Hematopoiesis of Indeterminate Potential and Cardiovascular Health - p. 13 10. Unique Challenges of Adult Congenital Heart Disease in CardioOncology - p. 25 11. Classes of Antineoplastic Agents Associated with Increased Risk of Cancer Therapy-associated Hypertension and Management Strategies - p. 31 12. Arrhythmia Challenges in Cardio-Oncology: High-Risk Therapies, Management, and Anticoagulation - p. 43 13. Ischemic Heart Disease in the Cancer Population: Trends, Outcomes, Epidemiology, and Challenges in Diagnosis and Treatment - p. 57 14. Cardiovascular Health in Breast Cancer: Survivorship Care - p. 69 15. Cardiovascular Risk in Prostate Cancer - p. 83 16. Evolving Strategies in Cardiac Amyloidosis: From Mechanistic Discoveries to Diagnostic and Therapeutic Advances - p. 93 17. Cardiotoxicity of Anthracyclines - p. 111 18. Cardiac Complications of Radiation Therapy - p. 129 19. Cardiac Complications of Immune Checkpoint Inhibitors and Chimeric Antigen Receptor T Cell Therapy - p. 151 20. Cardio-oncology Drug Interactions: A Primer for Clinicians on Select Cardiotoxic Oncologic Therapies - p. 169 21. Cardio-Oncology Program Building: A Practical Guide - p. 195
